ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.909,14
-0,25%
S&P 500
5.906,94
-1,07%
Dow Jones
42.573,73
-0,97%
Euro vs US Dollar
1,04108
0,05%
Bitcoin
94.047,61
1,49%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Esperion Therapeutics Inc (ESPR) Börsenkurse

Esperion Therapeutics Inc

Esperion Therapeutics Inc (ESPR)

NASDAQ
2,15
-0,13
(-5,70%)
Geschlossen 31 Dezember 10:00PM
Verzögert um 15 Minuten
2,14
-0,01
( -0,47% )
Vor Marktöffnung: 11:04AM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
2,14
Gebot
2,16
Fragen
2,32
Volumen
102
0,00 Tagesbereich 0,00
1,58 52-Wochen-Bereich 3,94
Marktkapitalisierung
421,655M
Handelsende
2,15
Handelsbeginn
-
Letzte Trade
1
@
2.14
Letzter Handelszeitpunkt
10:51:53
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
5.756.457
Ausgegebene Aktien
197.035.171
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,02
Gewinn pro Aktie (EPS)
-1,06
Erlöse
116,33M
Nettogewinn
-209,25M

Über Esperion Therapeutics Inc

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializi... Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.esperion.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Esperion Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ESPR. The last closing price for Esperion Therapeutics was US$2,15. Over the last year, Esperion Therapeutics shares have traded in a share price range of US$ 1,58 to US$ 3,94.

Esperion Therapeutics currently has 197.035.171 shares in issue. The market capitalisation of Esperion Therapeutics is US$423,63 million. Esperion Therapeutics has a price to earnings ratio (PE ratio) of -2.02.

ESPR Neueste Nachrichten

Weitere Nachrichten

Form 4 - Statement of changes in beneficial ownership of securities

18 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 Dezember 2024
Edgar (US Regulatory)

Form 8-K - Current report

18 Dezember 2024
Edgar (US Regulatory)

Esperion Strengthens Balance Sheet with Closing of Significant Refinancing Transactions

– $150 Million Senior Secured Term Loan Credit Facility and New $100 Million Convertible Note to Repay Significant Portion of Existing $265 Million Convertible Debt – – New Facility Represents...

18 Dezember 2024
GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities

17 Dezember 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

17 Dezember 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

17 Dezember 2024
Edgar (US Regulatory)

Form 8-K - Current report

13 Dezember 2024
Edgar (US Regulatory)

Esperion Announces $210 Million Convertible Debt Financing

ANN ARBOR, Mich., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Esperion (the “Company”) (NASDAQ: ESPR) today announced that it entered into privately negotiated exchange and subscription agreements (the...

13 Dezember 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.1-4.464285714292.242.362.1337568682.24327119CS
4-0.91-29.83606557383.053.941.840182871892.67830841CS
120.115.418719211822.033.941.8257564572.48441173CS
26-0.09-4.035874439462.233.941.5850717392.29849633CS
52-0.78-26.71232876712.923.941.5860912322.37830948CS
156-2.83-56.94164989944.978.870.736751972.72790825CS
260-57.63-96.419608499259.7779.9890.725500805.92871914CS

ESPR - Frequently Asked Questions (FAQ)

What is the current Esperion Therapeutics share price?
The current share price of Esperion Therapeutics is US$ 2,14
How many Esperion Therapeutics shares are in issue?
Esperion Therapeutics has 197.035.171 shares in issue
What is the market cap of Esperion Therapeutics?
The market capitalisation of Esperion Therapeutics is USD 423,63M
What is the 1 year trading range for Esperion Therapeutics share price?
Esperion Therapeutics has traded in the range of US$ 1,58 to US$ 3,94 during the past year
What is the PE ratio of Esperion Therapeutics?
The price to earnings ratio of Esperion Therapeutics is -2,02
What is the cash to sales ratio of Esperion Therapeutics?
The cash to sales ratio of Esperion Therapeutics is 3,64
What is the reporting currency for Esperion Therapeutics?
Esperion Therapeutics reports financial results in USD
What is the latest annual turnover for Esperion Therapeutics?
The latest annual turnover of Esperion Therapeutics is USD 116,33M
What is the latest annual profit for Esperion Therapeutics?
The latest annual profit of Esperion Therapeutics is USD -209,25M
What is the registered address of Esperion Therapeutics?
The registered address for Esperion Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Esperion Therapeutics website address?
The website address for Esperion Therapeutics is www.esperion.com
Which industry sector does Esperion Therapeutics operate in?
Esperion Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
EYENEyenovia Inc
US$ 0,2295
(102,56%)
57,93M
APMAptorum Group Ltd
US$ 2,64
(94,83%)
1,72M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,217
(75,57%)
49,24M
HAOHaoxi Health Technology Ltd
US$ 0,1962
(47,52%)
15,61M
NXUNXU Inc
US$ 2,20
(46,67%)
13,73M
SGMOSangamo Therapeutics Inc
US$ 1,16
(-50,43%)
634,87k
WATTEnergous Corporation
US$ 1,87
(-29,43%)
1,61M
AEIAlset Inc
US$ 0,9522
(-24,38%)
574k
XOMAXOMA Royalty Corporation
US$ 20,11
(-22,92%)
6
MSTXTidal Trust II Defiance Daily Target 2x Long MSTR ETF
US$ 41,01
(-22,65%)
555,77k
EYENEyenovia Inc
US$ 0,2298
(102,82%)
57,94M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,2167
(75,32%)
49,25M
SVMHSRIVARU Holding Ltd
US$ 0,0388
(16,17%)
41,11M
CRKNCrown Electrokinetics Corporation
US$ 0,1699
(22,49%)
21,09M
HAOHaoxi Health Technology Ltd
US$ 0,1954
(46,92%)
15,63M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
ESPR
Esperion Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten